CNS Pharmaceuticals, Inc. (CNSP) › Operating Cash FlowCNS Pharmaceuticals, Inc. (CNSP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$716.4K2019: -$3.55M2020: -$7.32M2021: -$13.54M2022: -$10.56M2023: -$14.14M2024: -$17.11M2025: -$13.81M-$13.81M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$13.81M+19.3%2024-$17.11M-21.0%2023-$14.14M-33.9%2022-$10.56M+22.0%2021-$13.54M-85.0%2020-$7.32M-105.9%2019-$3.55M-396.0%2018-$716.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share